EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Gold- or Silver-Nanoparticle SERS Platforms for Plasma-Based Diagnostics and AI-Driven Analysis

Gideon L Elizur iD, Alexandre Canhoto, Gabriela Soares iD, Lucio Studer Ferreira iD, Eulália Pereira iD, Ricardo Franco iD

Sensors · 30.06.2026 · 26 (13) · 4131

DOI: 10.3390/s26134131 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Sensors, online erschienen am 30.06.2026. Verfasst von Gideon L Elizur und 5 weiteren Autor:innen. Beteiligte Einrichtung: Associate Laboratory i4HB-Institute for Health and Bioeconomy, Faculdade de Ciências e Tecnologia, Universidade NOVA de Lisboa, 2819-516 Caparica, Po…. Hauptthemen laut MEDLINE: Spectrum Analysis, Raman, Metal Nanoparticles, Silver, Gold. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 277 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação para a Ciência e Tecnologia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Surface-enhanced Raman spectroscopy (SERS) has emerged as a highly promising analytical technique for disease diagnostics due to its exceptional sensitivity, molecular specificity, and ability to detect a broad range of biomarkers in complex biological matrices. This review provides a comprehensive overview of gold- and silver-nanoparticle-based SERS platforms for plasma disease diagnostics, covering advances in plasmonic nanostructures, biological sample analysis, biomarker detection, and AI-driven spectral data processing. Particular emphasis is placed on the application of SERS to clinically relevant biofluids, especially plasma, where the technique has demonstrated considerable potential for detecting diseases such as cancer, inflammatory disorders, and neurological conditions. The review also critically examines the major challenges currently limiting the clinical translation of SERS technologies. These include variability associated with substrate fabrication, matrix-induced signal fluctuations, limited interlaboratory reproducibility, and the lack of standardized protocols for spectral preprocessing and data analysis. Strategies proposed to address these issues are discussed, including comprehensive post-synthesis substrate characterization, optimization of biological sample preparation, advanced spectral preprocessing workflows, and the integration of machine learning and artificial intelligence algorithms to improve diagnostic robustness and reproducibility. Collectively, the advances summarized in this review indicate that SERS-based diagnostic technologies are rapidly progressing beyond proof-of-concept studies toward clinically applicable systems. Continued interdisciplinary collaboration and standardization efforts will be essential to bridge the remaining gap between experimental SERS methodologies and routine clinical implementation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Spectrum Analysis, RamanMetal NanoparticlesSilverGoldArtificial IntelligenceHumansBiomarkers

Stichwörter der Autor:innen

artificial intelligencegold nanoparticlesliquid biopsymachine learningplasma diagnosticsplasmonic nanoparticlessilver nanoparticlessurface-enhanced Raman spectroscopy (SERS)

Substanzen

SilverGoldBiomarkers

Autor:innen und Institutionen

  • Associate Laboratory i4HB-Institute for Health and Bioeconomy, Faculdade de Ciências e Tecnologia, Universidade NOVA de Lisboa, 2819-516 Caparica, Portugal.
  • UCIBIO-Applied Molecular Biosciences Unit, Departamento de Química, Faculdade de Ciências e Tecnologia, Universidade NOVA de Lisboa, 2819-516 Caparica, Portugal.
  • ISCTE-University Institute of Lisbon, 1649-026 Lisbon, Portugal.
  • COPELABS, Lusófona University, Campo Grande 376, 1749-024 Lisbon, Portugal.
  • INESC INOV-Lab, 1000-029 Lisbon, Portugal.
  • LAQV/REQUIMTE-Laboratório Associado para a Química Verde/Rede de Química e Tecnologia, Departamento de Química e Bioquímica, Faculdade de Ciências, Universidade do Porto, 4169-007 Porto, Portugal.

ORCID-Profile: Gideon L Elizur, Gabriela Soares, Lucio Studer Ferreira, Eulália Pereira, Ricardo Franco

Förderung

  • Fundação para a Ciência e Tecnologia

Zitieren

APA

Elizur, G. L., Canhoto, A., Soares, G., Ferreira, L. S., Pereira, E., & Franco, R. (2026). Gold- or Silver-Nanoparticle SERS Platforms for Plasma-Based Diagnostics and AI-Driven Analysis. Sensors, 26(13), 4131. https://doi.org/10.3390/s26134131

Vancouver

Elizur GL, Canhoto A, Soares G, Ferreira LS, Pereira E, Franco R. Gold- or Silver-Nanoparticle SERS Platforms for Plasma-Based Diagnostics and AI-Driven Analysis. Sensors. 2026;26(13):4131. doi:10.3390/s26134131

BibTeX
@article{Elizur2026,
  author = {Elizur, Gideon L and Canhoto, Alexandre and Soares, Gabriela and Ferreira, Lucio Studer and Pereira, Eulália and Franco, Ricardo},
  title = {Gold- or Silver-Nanoparticle SERS Platforms for Plasma-Based Diagnostics and AI-Driven Analysis},
  journal = {Sensors},
  year = {2026},
  volume = {26},
  number = {13},
  pages = {4131},
  doi = {10.3390/s26134131}
}
Kostenlos starten →